Amitiza ® — Net Sales
Viatris Amitiza ® — Net Sales decreased by 19.8% to $34.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.1%, from $33.30M to $34.00M. Over 4 years (FY 2021 to FY 2025), Amitiza ® — Net Sales shows a downward trend with a -5.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests strong market demand, effective commercial execution, or successful lifecycle management, while a decrease may indicate increased generic competition, patent expirations, or shifting therapeutic preferences.
Detailed definition
This metric represents the total revenue generated from the sale of the Amitiza product line, a specialized pharmaceutic...
Peer comparison
Comparable to product-specific revenue reporting in other pharmaceutical companies, often benchmarked against similar gastrointestinal or specialty drug franchises.
vtrs_segment_amitiza_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.10M | $49.50M | $54.00M | $41.80M | $44.10M | $39.40M | $42.60M | $36.60M | $41.50M | $37.70M | $41.20M | $33.00M | $36.90M | $38.20M | $41.10M | $33.30M | $41.60M | $40.80M | $42.40M | $34.00M |
| QoQ Change | — | -5.0% | +9.1% | -22.6% | +5.5% | -10.7% | +8.1% | -14.1% | +13.4% | -9.2% | +9.3% | -19.9% | +11.8% | +3.5% | +7.6% | -19.0% | +24.9% | -1.9% | +3.9% | -19.8% |
| YoY Change | — | — | — | — | -15.4% | -20.4% | -21.1% | -12.4% | -5.9% | -4.3% | -3.3% | -9.8% | -11.1% | +1.3% | -0.2% | +0.9% | +12.7% | +6.8% | +3.2% | +2.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's amitiza ® — net sales?
- Viatris (VTRS) reported amitiza ® — net sales of $34.00M in Q1 2026.
- How has Viatris's amitiza ® — net sales changed year-over-year?
- Viatris's amitiza ® — net sales increased by 2.1% year-over-year, from $33.30M to $34.00M.
- What is the long-term trend for Viatris's amitiza ® — net sales?
- Over 4 years (2021 to 2025), Viatris's amitiza ® — net sales has grown at a -5.9% compound annual growth rate (CAGR), from $201.50M to $158.10M.
- What does amitiza ® — net sales mean?
- The total revenue earned from sales of the Amitiza pharmaceutical product.